Use of Novel Agent PuraStat® for Post-Sphincterotomy Bleeding

Authors

Ananya Venkatesh, MD, Thomas Jefferson University HospitalFollow
Bertilia Tavarez, MD, MS, Thomas Jefferson University HospitalFollow
Pedra Palacios Argueta, MD, Thomas Jefferson University HospitalFollow
Donna Leet, MD, Thomas Jefferson University Hospital
Afshin Khan, MD, University of California, San Francisco
Abdul Kouanda, MD, Thomas Jefferson University Hospital
Anand Kumar, MD, Thomas Jefferson University HospitalFollow
Alana Persaud, MD, Thomas Jefferson University Hospital
Yasi Xiao, MD, Thomas Jefferson University HospitalFollow
Alexander Schlachterman, MD, Thomas Jefferson UniversityFollow
Thomas Kowalski, MD, Thomas Jefferson University HospitalFollow
Faisal Kamal, MD, Thomas Jefferson University HospitalFollow

Abstract

Endoscopic sphincterotomy is commonly performed during endoscopic retrograde cholangiopancreatography (ERCP). Endoscopic sphincterotomy (ES) is associated with adverse events such as bleeding.¹ PuraStat® is a new synthetic hemostatic gel being used for treatment of gastrointestinal bleeding. We aim to report and outcomes of PuraStat® for post-sphincterotomy bleeding.

Recommended Citation

Venkatesh, MD, Ananya; Tavarez, MD, MS, Bertilia; Palacios Argueta, MD, Pedra; Leet, MD, Donna; Khan, MD, Afshin; Kouanda, MD, Abdul; Kumar, MD, Anand; Persaud, MD, Alana; Xiao, MD, Yasi; Schlachterman, MD, Alexander; Kowalski, MD, Thomas; and Kamal, MD, Faisal (2025) "Use of Novel Agent PuraStat® for Post-Sphincterotomy Bleeding," The Medicine Forum: Vol. 26, Article 19.
Available at: https://jdc.jefferson.edu/tmf/vol26/iss1/19